4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000042
Chief Operating Officer sold 15,982 shares at an average $15.42 ($246,403)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J Chief Operating Officer | 2023-06-20 | Sale 10b5-1 | −8,885 | $14.94 | $132,704 | 49,570 | D: show line 1 in the form |
| Dowden Nathan J Chief Operating Officer | 2023-06-22 | Sale 10b5-1 | −7,097 | $16.02 | $113,700 | 42,473 | D: show line 2 in the form |
| Open-market sales · 15,982 sh · avg $15.42 · $246,403 | |||||||
Loading xslF345X04/wf-form4_168746675476462.xml…